Amarin Corp PLC (AMRN)
0.9129
+0.08
(+9.99%)
USD |
NASDAQ |
May 02, 16:00
0.9129
0.00 (0.00%)
After-Hours: 17:01
Amarin Cash and Short Term Investments (Quarterly): 320.66M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 320.66M |
September 30, 2023 | 320.66M |
June 30, 2023 | 312.91M |
March 31, 2023 | 304.37M |
December 31, 2022 | 309.36M |
September 30, 2022 | 303.70M |
June 30, 2022 | 313.23M |
March 31, 2022 | 362.56M |
December 31, 2021 | 454.13M |
September 30, 2021 | 479.14M |
June 30, 2021 | 508.93M |
March 31, 2021 | 514.74M |
December 31, 2020 | 500.93M |
September 30, 2020 | 561.86M |
June 30, 2020 | 550.28M |
March 31, 2020 | 542.24M |
December 31, 2019 | 644.59M |
September 30, 2019 | 673.21M |
June 30, 2019 | 221.77M |
March 31, 2019 | 211.09M |
December 31, 2018 | 249.23M |
September 30, 2018 | 81.89M |
June 30, 2018 | 102.26M |
March 31, 2018 | 129.05M |
December 31, 2017 | 73.64M |
Date | Value |
---|---|
September 30, 2017 | 79.09M |
June 30, 2017 | 85.46M |
March 31, 2017 | 96.08M |
December 31, 2016 | 98.25M |
September 30, 2016 | 117.56M |
June 30, 2016 | 72.49M |
March 31, 2016 | 81.36M |
December 31, 2015 | 106.96M |
September 30, 2015 | 118.98M |
June 30, 2015 | 136.05M |
March 31, 2015 | 161.20M |
December 31, 2014 | 119.54M |
September 30, 2014 | 135.44M |
June 30, 2014 | 150.53M |
March 31, 2014 | 164.28M |
December 31, 2013 | 191.51M |
September 30, 2013 | 225.88M |
June 30, 2013 | 149.43M |
March 31, 2013 | 201.78M |
December 31, 2012 | 260.24M |
September 30, 2012 | 215.11M |
June 30, 2012 | 250.26M |
March 31, 2012 | 245.82M |
December 31, 2011 | 116.60M |
September 30, 2011 | 125.86M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
221.77M
Minimum
Jun 2019
673.21M
Maximum
Sep 2019
431.54M
Average
454.13M
Median
Dec 2021
Cash and Short Term Investments (Quarterly) Benchmarks
Trinity Biotech PLC | 3.691M |
DBV Technologies SA | 141.37M |
Adaptimmune Therapeutics PLC | 146.94M |
Akari Therapeutics PLC | 3.845M |
Biodexa Pharmaceuticals Plc | 7.606M |